Showing 1 - 20 results of 57 for search '"ОСТЕОДИСТРОФИЯ"', query time: 0.67s Refine Results
  1. 1
  2. 2
    Academic Journal
  3. 3
  4. 4
  5. 5
  6. 6
    Academic Journal

    Source: Research and Practical Medicine Journal; Том 5, № 1 (2018); 96-105 ; Research'n Practical Medicine Journal; Том 5, № 1 (2018); 96-105 ; 2410-1893 ; 10.17709/2409-2231-2018-5-1

    File Description: application/pdf

    Relation: https://www.rpmj.ru/rpmj/article/view/248/229; Макаров И. В. Гиперпаратиреоз: Учебно-методическое пособие для интернов, клинических ординаторов, врачей общей практики, эндокринологов и хирургов. Самара: ООО «Офорт», 2014, 132 с.; Youanes NA, Shafagoij Y, Khatib F, Ababneh M: Laboratory screening for hyperparathyroidism. Clin Chim Acta. 2005 Mar;353 (1–2):1–12. DOI:10.1016/j.cccn.2004.10.003; In Khan AA, Clark OH (Eds): Handbook of Parathyroid Diseases. Springer New York 2012, 75–92.; Lentle BC, Prior JC Osteoporosis: What a clinician expects to learn from a patient’s bone density examination. Radiology. 2003 Sep;228 (3):620–8. DOI:10.1148/radiol.2283020093; Vera L, Dolcino M, Mora M, Oddo S, Gualco M, Minuto F, Giusti. Primary hyperparathyroidism diagnosed after surgical ablation of a costal mass mistaken for giant-cell bone tumor: a case report. J Med Case Rep. 2011 Dec 28;5:596. DOI:10.1186/1752–1947–5-596; Kearns AE, Thompson GB. Medical and surgical management of hyperparathyroidism. Mayo Clin Proc. 2002 Jan;77 (1):87–91. DOI:10.4065/77.1.87; Campuzano-Zuluaga G, Velasco-Perez W, Marian-Zuluaga JI. A 60-year-old man with chronic renal failure and a costal mass: a case report and review of the literature. J Med Case Rep. 2009 Aug 4;3:7285. DOI:10.4076/1752–1947–3-7285.; Sywak MS, Knowlton ST, Pasieka JL, Parsons LL, Jones J. Do the National Institutes of Health Consensus Guidelines for Parathyroidectomy predict symptom severity and surgical outcome in patients with primary hyperparathyroidism? Surgery. 2002 Dec;132 (6):1013–9; discussion 1019–20. DOI:10.1067/msy.2002.128693; Rubin MR, Livolsi VA, Bandiera F, Caldas G, Bilezikian JP. Tc99 m-sestamibi uptake in osteitis fi brosa cystica simulating metastatic bone disease. J Clin Endocrinol Metab. 2001 Nov;86 (11):5138–41. DOI:10.1210/jcem.86.11.7994; Kar DK, Gupta SK, Agarwal A, Mishra SK. Brown tumor of the palate and mandible in association with primary hyperparathyroidism. J Oral Maxillofac Surg. 2001 Nov;59 (11):1352–4. DOI:10.1053/joms.2001.27533; Fernandez-Sanroman J, Anton-Badiola IM, Costas-Lopez A. Brown tumor of the mandible as first manifestation of primary hyperparathyroidism: diagnosis and treatment. Med Oral Patol Oral Cir Bucal. 2005 Mar-Apr;10 (2):169–72.; Takeshita T, Takeshita K, Abe S, Takami H, Imamura T, Furui S. Brown tumor with fl uid-fl uid levels in a patient with primary hyperparathyroidism: radiological fi nding. Radiat Med. 2006 Nov;24 (9):631–4. DOI:10.1007/s11604–006–0068–4; Pinto MC, Sass SM, Sampaio CP, Campos DS. Brown tumor in a patient with hyperparathyroidism secondary to chronic renal failure. Braz J Otorhinolaryngol. 2010 May-Jun;76 (3):404.; Fraser WD. Lancet. 2009 Jul 11;374 (9684):145–58. DOI:10.1016/S0140–6736 (09)60507–9.; Каприн А. Д., Галкин В. Н., Жаворонков Л. П., Иванов В. К., Иванов С. А., Романко Ю. С. Синтез фундаментальных и прикладных исследований — основа обеспечения высокого уровня научных результатов и внедрения их в медицинскую практику. Радиация и риск. 2017;26 (2):26–40. DOI:10.21870/0131–3878–2017–26–2-26–40.; https://www.rpmj.ru/rpmj/article/view/248

  7. 7
  8. 8
  9. 9
    Academic Journal

    Source: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 62, № 4 (2017); 93-98 ; Российский вестник перинатологии и педиатрии; Том 62, № 4 (2017); 93-98 ; 2500-2228 ; 1027-4065 ; 10.21508/1027-4065-2017-62-4

    File Description: application/pdf

    Relation: https://www.ped-perinatology.ru/jour/article/view/532/524; Martin Е., Bourdillon J. Un cas de tetanie idio-pathique chronique: echec therapeutique de la grele d’un adenome parathyro’idien. Rev Med Suisse 1940; 60: 1166–1177.; Albright F., Burnett С.H., Smith P.H., Parson W. Pseudo-hypoparathyroidism – an example of «Seabright–Bantam syndrome»: report of three cases. Endocrinology 1942; 30: 922–932.; http://www.orpha.net/consor/ (Дата обращения 14.04.2017); Mantovani G. Pseudohypoparathyroidism: Diagnosis and Treatment. J Clin Endocrinol Metab 2011; 96 (10): 3020– 3030. DOI:10.1210/jc.2011–1048.; OMIM (Online Mendelian Inheritance in Man): www.ncbi.nlm.nih.gov/OMIM (дата обращения 14.04.2017); Cho S.Y., Yoon Y.A., Ki C.S., Huh H.J., Yoo H.W., Lee B.H. et al. Clinical characterization and molecular classification of 12 Korean patients with pseudohypoparathyroidism and pseudopseudohypoparathyroidism. Exp Clin Endocrinol Diabetes 2013; 121(9):539-545. DOI:10.1055/s-0033-1349867; de Sanctis L., Bellone J., Salerno M., Faleschini E., Caruso-Nicoletti M., Cicchetti M. et al. GH secretion in a cohort of children with pseudohypoparathyroidism type Ia. J Endocrinol Invest 2007; 30: 97–103. DOI:10.1007/BF03347406; Muniyappa R., Warren M.A., Zhao X., Aney S.C., Courville A.B., Chen K.Y. et al. Reduced insulin sensitivity in adults with pseudohypoparathyroidism type 1a. J Clin Endocrinol Metab 2013; 98(11):1796-801. DOI:10.1210/jc.2013–1594.; Потешкин Ю.Е. Клинический случай псевдогипопаратиреоза у мужчины 33 лет. Фарматека 2013; 16 (269): 92-95. [Poteshkin Yu.E. Clinical case pseudohypoparathyroidism men 33 years. Farmateka 2013; 16 (269): 92–95. (in Russ)]; Wu Y.L., Hwang D.Y., Hsiao H.P., Ting W.H., Huang C.Y., Tsai W.Y. et al. Mutations in Pseudohypoparathyroidism 1a and Pseudopseudohypoparathyroidism in Ethnic Chinese. PLoS One 2014; 9(3): e90640. DOI:10.1371/journal.pone.0090640; Elli F.M., de Sanctis L., Bollati V., Tarantini L., Filopanti M., Barbieri A.M. et al. Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations. J Clin Endocrinol Metab 2014; 99(3): 508–517. DOI:10.1210/jc.2013-3086; Fernández-Rebollo E.I., Lecumberri B., Gaztambide S., Mar-tinez-Indart L., Perez de Nanclares G., Castaño L., Spanish PHP Group. Endocrine profile and phenotype-(epi)genotype correlation in Spanish patients with pseudohypoparathyroidism. J Clin Endocrinol Metab 2013; 98(5):996–1006. DOI:10.1210/jc.2012-4164; Hacıhamdioğlu B., Arslan M., Sarı E., Kurtçu K., Yesilkaya E. Brachydactyly mental retardation syndrome in differential diagnosis of pseudopseudohypoparathyroidism. J Pediatr En-docrinol Metab 2013; 26 (7-8): 793–795. DOI:10.1515/jpem-2012-0375; Маказан Н.В., Орлова Е.М., Карева М.А. Псевдогипопаратиреоз. Проблемы эндокринологии 2015; 61 (3): 47-56. [Makazan N.V., Orlova E.M., Kareva M.A. Pseudohypoparathyroidism. Problemy ehndokrinologii 2015; 61 (3): 47–56. (in Russ)]; Otheman Y., Khalloufi H., Benhima I., Ouanass A. Manifestations neuropsychiatriques révélant une pseudohypoparathyroïdie avec un syndrome de Fahr. L'Encéphale 2011; 37 (1): 54–58. Doi:10.1016/j.encep.2010.03.001; Adegbite N.S., Xu M., Kaplan F.S., Shore E.M., Pignolo R.J. Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS-based heterotopic ossification. Am J Med Genet A 2008; 146A: 1788– 1796. DOI:10.1002/ajmg.a.32346; Turan S.I., Fernandez-Rebollo E., Aydin C., Zoto T., Reyes M., Bounoutas G. et al. Postnatal establishment of allelic Gαs silencing as a plausible explanation for delayed onset of parathyroid hormone resistance owing to heterozygous Gαs disruption. Bone Miner Res 2014; 29 (3): 749–760. DOI:10.1002/jbmr.2070; Long D.N., LevineM.A., Germain-Lee E.L. Bone mineral density in pseudohypoparathyroidism type 1a. J Clin Endocrinol Metab 2010; 95: 4465–4475.; Bringhurst F.R., Demay M.B., Kronenberg H.M. Hormones and disorders of mineral metabolism. In: S. Melmed, K.S. Polonsky, P.R. Larsen, H.M. Kronenberg (eds). Williams Textbook of Endocrinology. 12th ed. Philadelphia: Saunders Else-vier 2011; 1237–1304.; Mantovani G., Ferrante E., Giavoli C., Linglart A., Cappa M., Cisternino M. et al. Recombinant human GH replacement therapy in children with pseudohypoparathyroidism type Ia: first study on the effect on growth. J Clin Endocrinol Metab 2010; 95: 5011–5017. DOI:10.1210/jc.2010-1649; Fernandez-Rebollo E., Perez de Nanclares G., Lecumberri B., Turan S., Anda E., Pérez-Nanclares G. et al. Exclusion of the; GNAS locus in PHP-Ib patients with broad GNAS methylation changes: evidence for an autosomal recessive form of PHP-Ib? J Bone Miner Res 2011; 26: 1854–1863. DOI:10.1002/jbmr.408; Bastepe M. Genetics and epigenetics of parathyroid hormone resistance. Endocr Dev 2013; 24: 11–24. DOI:10.1159/000342494. Epub 2013 Feb 1; Николаева Е.А. Значение достижений медицинской генетики для решения проблемы нарушения развития у детей. Рос вестн перинатол и педиатр 2016; 61 (2): 5–11. [Nikolaeva E.A. Significance of the achievements of medical genetics to solve developmental disorders in children. Ros vestn perinatal i pediatr 2016; 61 (2): 5–11. DOI:10.21508/1027-4065-2016-61-2-5-11 (in Russ)]

  10. 10
  11. 11
  12. 12
    Academic Journal

    Source: Scientific studies: from theory to practice; № 2(8); 15-17 ; Научные исследования: от теории к практике; № 2(8); 15-17 ; ISSN: 2413-3957 ; 2413-3957

    File Description: text/html

    Relation: info:eu-repo/semantics/altIdentifier/pissn/2413-3957; https://interactive-plus.ru/e-articles/220/Action220-111381.pdf; 1. Луцкий Я.Я. Патология обмена веществ у высокопродуктивных коров / Я.Я. Луцкий [и др.]. – М.: Колос, 1984. – С. 241–250.; 2. Коваль М.П. Лечение и профилактика остеодистрофии. – Колос, 1978. – С. 214–222.; 3. Пименов П.К. Остеодистрофия крупного рогатого скота при откорме и ее профилактика / П.К. Пименов, В.В. Богатырев // Ветеринария. – 1993. – №5. – С. 63.

  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20